Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Habib Hamidi

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Current Opinion in Nephrology and Hypertension|August 4, 2018
Systems biology approaches to identify disease mechanisms and facilitate targeted therapy in the management of glomerular diseaseHabib Hamidi, Matthias Kretzler
Cancer Research|July 23, 2003
Functional analysis of the EWS/ETS target gene uridine phosphorylaseBenjamin Deneen, Habib Hamidi, Christopher T Denny
Plos One|June 4, 2011
Identification of novel targets of CSL-dependent Notch signaling in hematopoiesisHabib Hamidi, Derek Gustafason, Matteo Pellegrini, et al.
Diabetes, Obesity & Metabolism|October 9, 2018
An integrative systems biology approach for precision medicine in diabetic kidney diseaseSkander Mulder, Habib Hamidi, Matthias Kretzler, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 30, 2020
Systems Biology and Kidney DiseaseJennifer A Schaub, Habib Hamidi, Lalita Subramanian, et al.
Personalized Medicine|June 8, 2026
Toward a harmonized assessment of MRD by NGS: blinded pilot study of NGS assays by MPAACT consortiumVanessa Obourn, Shalaka Patel, Gonzalo Lopez, et al.
Translational Oncology|October 24, 2022
Tetramer-aided sorting and single-cell RNA sequencing facilitate transcriptional profiling of antigen-specific CD8+ T cellsKamalakannan Rajasekaran, Xiangnan Guan, Alireza Tafazzol, et al.
Frontiers in Oncology|August 29, 2022
Immune microenvironment characteristics in multiple myeloma progression from transcriptome profilingJin Wang, Yi Hu, Habib Hamidi, et al.
Annals of the New York Academy of Sciences|April 8, 2009
Inferring direct regulatory targets of a transcription factor in the DREAM2 challengeVinsensius B Vega, Xing Yi Woo, Habib Hamidi, et al.
Plos One|February 14, 2013
Dacomitinib, an irreversible Pan-ErbB inhibitor significantly abrogates growth in head and neck cancer models that exhibit low response to cetuximabFerdows Ather, Habib Hamidi, Marlena S Fejzo, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Current Opinion in Nephrology and Hypertension|August 4, 2018
Systems biology approaches to identify disease mechanisms and facilitate targeted therapy in the management of glomerular diseaseHabib Hamidi, Matthias Kretzler
Cancer Research|July 23, 2003
Functional analysis of the EWS/ETS target gene uridine phosphorylaseBenjamin Deneen, Habib Hamidi, Christopher T Denny
Plos One|June 4, 2011
Identification of novel targets of CSL-dependent Notch signaling in hematopoiesisHabib Hamidi, Derek Gustafason, Matteo Pellegrini, et al.
Diabetes, Obesity & Metabolism|October 9, 2018
An integrative systems biology approach for precision medicine in diabetic kidney diseaseSkander Mulder, Habib Hamidi, Matthias Kretzler, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 30, 2020
Systems Biology and Kidney DiseaseJennifer A Schaub, Habib Hamidi, Lalita Subramanian, et al.
Personalized Medicine|June 8, 2026
Toward a harmonized assessment of MRD by NGS: blinded pilot study of NGS assays by MPAACT consortiumVanessa Obourn, Shalaka Patel, Gonzalo Lopez, et al.
Translational Oncology|October 24, 2022
Tetramer-aided sorting and single-cell RNA sequencing facilitate transcriptional profiling of antigen-specific CD8+ T cellsKamalakannan Rajasekaran, Xiangnan Guan, Alireza Tafazzol, et al.
Frontiers in Oncology|August 29, 2022
Immune microenvironment characteristics in multiple myeloma progression from transcriptome profilingJin Wang, Yi Hu, Habib Hamidi, et al.
Annals of the New York Academy of Sciences|April 8, 2009
Inferring direct regulatory targets of a transcription factor in the DREAM2 challengeVinsensius B Vega, Xing Yi Woo, Habib Hamidi, et al.
Plos One|February 14, 2013
Dacomitinib, an irreversible Pan-ErbB inhibitor significantly abrogates growth in head and neck cancer models that exhibit low response to cetuximabFerdows Ather, Habib Hamidi, Marlena S Fejzo, et al.
Pageof 5